Hollenhorst Plaque: From A to Z blog Ophthalmology Education

Case Study

A 72-year-old male with a history of hyperlipidemia, hypertension, and coronary artery disease presented to an ophthalmology clinic with sudden, painless vision loss in his right eye.

Get the All-fit Adapter

The patient reported that the vision loss occurred a few hours prior and described it as a “shadow” in his visual field.

He denied any associated eye pain, flashes of light, or floaters. His medical history was significant for a myocardial infarction three years ago and a recent carotid artery stenosis diagnosed six months earlier.

Examination Results:

Visual Acuity: 20/100 in the right eye, 20/30 in the left eye.
Fundus Examination: Yellowish, a refractile plaque at the bifurcation of a retinal arteriole in the right eye, consistent with a Hollenhorst plaque. Mild retinal edema was also noted.
Fluorescein Angiography: Delayed arterial filling in the affected vessel with no evidence of neovascularization.
Intraocular Pressure (IOP): 16 mmHg in both eyes.
Carotid Doppler Ultrasound: Confirmed significant carotid artery stenosis.

A diagnosis of Hollenhorst Plaque, secondary to carotid artery disease, was made.

Hollenhorst Plaque Disease Entity

Hollenhorst plaques are cholesterol emboli that lodge in the retinal arterioles, typically at branch points and are often associated with systemic atherosclerotic disease.

These plaques are named after Dr. Robert Hollenhorst, who first described them in the 1960s. They appear as yellowish, refractile bodies within the retinal vasculature and are an important sign of underlying vascular pathology.

Pathophysiology

Hollenhorst plaques originate from atheromatous plaques within larger arteries, such as the carotid arteries or aorta.

When these atheromatous plaques rupture or ulcerate, cholesterol crystals and other embolic material are released into the bloodstream.

These emboli travel through the circulatory system and can lodge in smaller vessels, such as the retinal arterioles.

The presence of a Hollenhorst plaque indicates embolization, which is a marker for significant atherosclerosis and increased risk of cerebrovascular and cardiovascular events.

The plaque’s characteristic appearance is due to its high cholesterol content, which reflects light, making it highly visible during fundoscopic examination.

The location of the plaque within the retinal circulation can lead to varying degrees of retinal ischemia, depending on the size and extent of the blockage.

While some patients may experience transient or permanent vision loss, others may be asymptomatic, with the plaque discovered incidentally during a routine eye examination.

Hollenhorst Plaque Epidemiology

Hollenhorst plaques are more commonly found in older adults, particularly those with significant cardiovascular risk factors such as hyperlipidemia, hypertension, diabetes mellitus, and a history of smoking.

The prevalence of Hollenhorst plaques increases with age, and they are more frequently observed in patients with known carotid artery disease or other forms of systemic atherosclerosis.

Although the presence of a Hollenhorst plaque is relatively uncommon in the general population, its detection warrants thorough systemic evaluation, as it is a harbinger of potentially life-threatening conditions such as stroke and myocardial infarction.

The incidence of Hollenhorst plaques in patients undergoing carotid endarterectomy ranges from 1% to 5%, indicating a strong association with carotid artery disease.

Clinical Features

The clinical presentation of Hollenhorst plaques can vary widely, depending on the extent of retinal ischemia and the presence of other ocular or systemic conditions. Common clinical features include:

Sudden Vision Loss: Patients may present with sudden, painless vision loss, which can range from mild blurring to significant visual field defects. In some cases, the vision loss may be transient, resolving within minutes to hours.
Asymptomatic Findings: Many Hollenhorst plaques are discovered incidentally during routine fundoscopic examination in asymptomatic patients.
Amaurosis Fugax: Some patients may experience brief episodes of transient monocular vision loss, known as amaurosis fugax, which is often a warning sign of impending stroke.
Embolic Events: The presence of a Hollenhorst plaque may be associated with other embolic phenomena, such as transient ischemic attacks (TIAs) or cerebrovascular accidents (CVAs).

Examination Findings

Fundus Examination: The hallmark of Hollenhorst plaques is the presence of a yellowish, refractile embolus lodged within a retinal arteriole, typically at a bifurcation. The surrounding retina may show signs of ischemia, such as retinal edema or cotton-wool spots.
Fluorescein Angiography: This imaging modality may demonstrate delayed or absent filling of the affected arteriole, along with areas of capillary dropout or nonperfusion.
Optical Coherence Tomography (OCT): May reveal retinal thickening or structural changes secondary to ischemia.
Carotid Doppler Ultrasound: Essential for identifying the source of emboli, particularly in patients with suspected carotid artery disease.

Hollenhorst Plaque Differential Diagnosis

The differential diagnosis of Hollenhorst plaques includes other causes of retinal emboli and retinal ischemia:

Calcific Emboli: Typically larger and more solid than Hollenhorst plaques, these emboli originate from calcified heart valves or atherosclerotic plaques.
Fibrin-Platelet Emboli: These emboli are often smaller and less refractile and are associated with thromboembolic events such as atrial fibrillation.
Retinal Artery Occlusion: Sudden vision loss with a cherry-red spot on the macula may indicate central or branch retinal artery occlusion.
Diabetic Retinopathy: Microaneurysms, hemorrhages, and neovascularization are more characteristic of diabetic retinopathy.

Hollenhorst Plaque Diagnosis

The diagnosis of Hollenhorst plaque is primarily based on clinical examination and imaging studies:

Fundus Examination: Direct visualization of the characteristic plaque is crucial for diagnosis.
Fluorescein Angiography: Useful in assessing the extent of retinal ischemia and capillary nonperfusion.
Carotid Doppler Ultrasound: Recommended to identify the source of emboli, particularly in patients with carotid artery disease.
Systemic Evaluation: A thorough cardiovascular workup, including echocardiography and lipid profile, is essential for managing the underlying atherosclerotic disease.

Hollenhorst Plaque Management

Management of Hollenhorst plaques involves addressing the underlying systemic atherosclerosis and reducing the risk of further embolic events:

Cardiovascular Risk Management: Tight control of blood pressure, cholesterol levels, and blood sugar is essential. Lifestyle modifications, such as smoking cessation and regular exercise, are also crucial.
Antiplatelet Therapy: Aspirin or other antiplatelet agents may be prescribed to reduce the risk of stroke and other thromboembolic events.
Carotid Endarterectomy: In patients with significant carotid artery stenosis, surgical intervention may be necessary to prevent further embolization.
Regular Monitoring: Patients with Hollenhorst plaques require ongoing follow-up to monitor for recurrent embolic events and to ensure optimal management of systemic risk factors.

Prognosis

The prognosis for patients with Hollenhorst plaques depends largely on the management of the underlying systemic condition.

While the visual prognosis may be favorable, with some patients experiencing spontaneous improvement in vision, the presence of a Hollenhorst plaque is a marker for significant cardiovascular risk.

Without appropriate intervention, these patients are at increased risk of stroke, myocardial infarction, and other serious vascular events.

Prevention

Prevention of Hollenhorst plaques involves the control of systemic atherosclerotic disease:

Healthy Lifestyle: A diet low in saturated fats and cholesterol, regular physical activity, and avoidance of tobacco can significantly reduce the risk of atherosclerosis.
Regular Medical Check-Ups: Routine monitoring of blood pressure, lipid levels, and blood sugar can help identify and manage risk factors early.
Patient Education: Educating patients about the signs and symptoms of stroke and other vascular events can lead to earlier intervention and better outcomes.

Conclusion

Hollenhorst plaques are a critical indicator of systemic atherosclerotic disease and require prompt recognition and management.

Understanding the pathophysiology, clinical features, and appropriate interventions is essential for preventing serious vascular events in affected patients.

Regular monitoring and control of cardiovascular risk factors are crucial in improving the long-term prognosis for these individuals.

Would you have interest in taking retinal images with your smartphone?

Fundus photography is superior to fundus analysis as it enables intraocular pathologies to be photo-captured and encrypted information to be shared with colleagues and patients.

Recent technologies allow smartphone-based attachments and integrated lens adaptors to transform the smartphone into a portable fundus camera and Retinal imaging by smartphone.

RETINAL IMAGING BY YOUR SMARTPHONE

References

Hayreh, S. S. (2001). Retinal and optic nerve head ischemic disorders and atherosclerosis: Role of embolism, thrombosis, and venous stasis.
Brown, G. C., & Magargal, L. E. (1980). The Hollenhorst plaque: Its incidence, association with carotid artery disease, and possible risk factors.
Rogers, S. L., McIntosh, R. L., & Wong, T. Y. (2010). Retinal artery occlusion and embolic sources: A systematic review.
Bruno, A., Jones, W., & Austin, J. K. (1992). Vascular risk factors associated with retinal emboli: The Cardiovascular Health Study.
Mitchell, P., Wang, J. J., & Li, W. (2005). Retinal emboli and risk of stroke: The Blue Mountains Eye Study.